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It is well known that the kidney regenerates bicarbonate
largely through its ability to excrete ammonia'. In most physi-
ological circumstances, the majority of this ammonia is pro-
duced within the kidney itself through the intrarenal deamida-
tion and demination of glutamine [1, 2], a process that leaves
behind an organic anion (mainly alphaketoglutarate) once the
nitrogens are removed [1, 2]. The excretion of the NH4
so-formed in the urine prevents the nitrogens of glutamine from
being transported to the liver and converted into urea (a
bicarbonate-consuming process) [1]. Usually, the carbon skel-
eton of glutamine is metabolized within the kidney cortex. The
conversion of a-ketoglutarate into a neutral compound
(glucose°, C020:8) in the kidney (or in another organ) will
generate two bicarbonate ions since two negative charges are
present on the a-ketoglutarate anion, that is, the conversion of
an anion into a neutral compound consumes a proton or
generates a bicarbonate ion [2] (see reactions 1 and 2 below).
Glutamine° —* 3 C02° + 2 NH4t + 2 HC03
Glutamine° —* glucose° + 2 NH4 + 2 HCO
The net effect of these two phenomena, that is, the intrarenal
metabolism of the carbon skeleton of glutamine, and the segre-
gation of ammonium into the urine, is responsible for the
generation of bicarbonate in (or the removal of protons from)
the body fluids. This process is stoichiometrically related to
ammonium excretion [2] (Fig. 1).
By contrast, when glutamine is catabolized within the liver to
C02° or glucose°, no net generation of ammonium and bicar-
bonate occurs because the ammonium liberated is converted
rapidly into urea plus a proton (see reactions 3 and 4).
Glutamine° —t 5 C02° + urea°
Glutamine° —' glucose° + 2 C020+ urea°
The renal metabolism of the carbon chain of glutamine
coupled with the excretion of urinary ammonium thus can be
viewed as the counterpart of those metabolic processes which
Ammonia is used in this text as the sum of NH4t + NH,.6 The
charges on molecules are indicated by a + (cations), — (anions-) or
o (neutral°).
generate strong nonvolatile acids, that is, the oxidation of
sulfur-containing aminoacids to H2S04. Therefore, mainte-
nance of acid-base balance in part depends on the relative rates
of these metabolic processes; the generation of nonvolatile
acids within the liver are normally neutralized by the metabolic
production of bicarbonate occurring in the kidney (Fig. 1).
Two mechanisms must regulate the net metabolic production
of bicarbonate linked to renal ammoniagenesis: (1) the distribu-
tion of NH4t produced in the kidney cortex between the renal
vein and the urine and (2) the metabolic regulation of the
production of ammonia occurring mainly in proximal tubular
cells.
On one hand, because the distribution of the NH4t between
urine and renal venous blood depends on the flow and pH of
these two components [3—5], a significant portion (30 to 50%) of
the ammonia produced by the kidney is found in the renal vein
and not excreted in the urine. Therefore, the factors responsible
for the accumulation of NH4t in the urine versus the renal vein
will modify the net NH4t excretion independently of the rate of
ammoniagenesis [3—5], and therefore, the net generation of
bicarbonate by the kidney (Fig. 1).
On the other hand, the amount of ammonium excreted into
the urine is influenced by the rate of glutamine metabolism and
ammonia production within proximal tubular cells [5, 6]. At this
site, the hydrogen ion concentration directly influences meta-
bolic processes within the kidney: Acidosis accelerates the
renal conversion of glutamine [5, 6] (and reduces that of lactate
[7]) into glucose (rat kidney [8]) or into CO2 (dog kidney [9, 10]).
The partition of the NH4t between urine and renal vein and the
regulation of renal ammoniagenesis may have additive effects
on the acid-base balance (as in chronic metabolic acidosis) or
inverse effects (as in lactate-induced metabolic alkalosis, see
below). In other words, the effect of an accelerated ammonia-
genesis in proximal tubules can be amplified or blunted by the
mechanisms controlling the rate of NH4 transfer in the urine
(Fig. 1). In special situations, when ammonia production is
stimulated markedly by factors other than Ht concentration,
and unaccompanied by a significant change in urinary NH4t
excretion (see below), ammoniagenesis will have little effect on
acid-base balance. Clearly, it is impossible to study the regula-
tion of renal ammoniagenesis without simultaneously monitor-
ing the total ammonia production (urinary plus renal vein
release) and the net acid-base effect of this process (stoichio-
metrically related to the urinary excretion of NH4t).
In this review, we focus on the effects of various acid-base
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dog kidney originates from sources other than glutamine (for
example, other amino acids). The total ammonia production by
the kidney will be the sum of these various processes and may
be modified consequently by factors unrelated to the defense of
systemic pH. Third, we will comment on the energy balance
aspect (ATP turnover) of these various metabolic events within
the kidney and define upper and lower limits to the am-
moniagenic process in the dog.
To illustrate these three points, we will compare the systemic
and renal effects of various acid-base disorders in the dog. More
specifically, studies performed in normal dogs will be compared
with those performed in dogs made acutely (HCI infusion [10] or
CO2 inhalation [16]) or chronically acidotic (ammonium chlo-
ride feeding for 5 to 7 days). To compare acidosis of inorganic
and organic origins, a dog group infused with lactic acid will
also be examined. Conversely, the effect of alkalosis will be
studied in dogs made acutely alkalotic through either bicarbon-
ate [17] or lactate infusion [18]. The data obtained in these
seven dog groups will be compared to illustrate the adaptation
of various metabolic processes to acid-base changes in the dog
kidney.
disorders on the renal metabolism of glutamine in the dog
kidney. We have selected the dog because it is much easier to
measure the renal utilization or production of various metabo-
lites through repetitive measurements in arterial and renal
venous blood in this species than in the rat. Furthermore, the
renal adaptation of the dog kidney to metabolic acidosis appears
to be closer to the response of humans in several respects. It
must be stressed that considerable metabolic differences exist
between the response of rat and dog proximal tubules to
metabolic acidosis. Therefore, observations in the rat kidney
are often inapplicable to the dog kidney and by analogy to the
human kidney [11, 121. For example, the effects of acidosis on
the activity of various enzymes of the ammoniagenic pathway
such as phosphate-dependent glutaminase [10, 13, 14], on the
concentration of critical metabolites within the kidney cortex
such as malate [10, 15], and on the maximal rate of renal
ammoniagenesis, and so forth, are markedly different in the rat
and dog. Because most studies examining the regulation of
renal ammoniagenesis were performed in rats, concepts origi-
nating from these observations must be analyzed critically
regarding these metabolic differences, before applying them to
other species. This has not been realized fully in the past and
justifies our attempt to describe the ammoniagenesis of the dog
kidney.
The following aspects of glutamine metabolism and ammo-
niagenesis will be illustrated in this review: First, the renal
metabolism of glutamine is not an isolated event but one of
several metabolic processes occurring simultaneously in prox-
imal tubules of the dog. Therefore, during metabolic acidosis or
alkalosis of various origins, the understanding of the regulation
of renal glutamine metabolism involves the knowledge of the
simultaneous metabolism of other critical metabolites such as
lactate, citrate, and so forth, Second, ammonia production in
the dog kidney arises from different ammoniagenic processes
which occur simultaneously. Some of these processes utilizing
glutamine are regulated by acid-base balance (glutamate dehy-
drogenase flux) and others by substrate availability (aminotran-
ferases flux). Furthermore, part of the ammonia produced in the
Systemic effects of acid-base changes
The precursor for renal ammonia synthesis is plasma
glutamine which is extracted continuously from the arterial
blood by the dog kidney [6, 10]. Although, other aminoacids
(alanine, glycine, aspartate, and so forth) can serve as precur-
sors for renal ammoniagenesis [19] when infused at
supraphysiological rates into dogs, they are not physiological
precursors for ammoniagenesis in the kidney [5, 6, 9, 10]. In
contrast, alanine and serine are released by the kidney under
normal conditions [20, 21]. The identification of glutamine as
the main ammoniagenic substrate implies that extrarenal
(glutamine synthesis) and intrarenal (glutamine utilization) com-
ponents of the ammoniagenic pathway must coexist.
Glutamine is supplied to the body fluids following the diges-
tion of dietary proteins. However, most of the ingested
glutamine is deamidated in the gut into ammonia and glutamate
(which may transaminate to form alanine). It is under these
forms that dietary glutamine gains access to the liver through
the portal vein [22]. At this site, glutamine will be resynthetized
by the perivenous hepatocytes [23] via the energy-dependent
glutamine synthetase reaction (see reaction 5).
Glutamate + NH4 + ATP—. Glutamine° + ADP + Pi (5)
Therefore, despite the fact that the quantity of glutamine in a
normal diet greatly exceeds the potential need of this amino
acid to neutralize the dietary acid load, most of the glutamine
used by the kidney must be synthetized actively. This process
has been considered a possible regulatory point of the am-
moniagenic pathway [24, 25]. However, this does not appear to
be the case because the maximal rate of glutamine metabolism
in dog kidneys (approximately 80 mmoles/day during chronic
metabolic acidosis) represents only a small proportion of the
overall glutamine turnover [26] even in normal animals, A
similar situation is found in the rat [27]. Furthermore, arterial
blood glutamine is little affected by acid-base changes [10, 28].
Hence, organs other than the kidney appear to contribute to the
maintenance of a normal blood glutamine concentration. In this
regard, it must be recalled that glutamine is the main fuel for the
/Renal vein:
2 HCO
systemic HCO3
Glutamine +
2 NH4
Urine:
Systemic HCO3 gain
I I
_________ __________
Ammonia production Systemic acid-base effect
Fig. 1. Production of NH4* in the kidney and the net generation of
bicarbonate due to this process. This figure illustrates that the renal
metabolism of glutamine (of alphaketoglutarate) constitutes a net
bicarbonate generating process only when the NH4 produced is
excreted into the urine. If the ammonia is diverted to the liver via the
renal vein, the ureagenic process consumes the bicarbonate produced
during the metabolism of KG , and no net systemic gain of bicarbonate
is obtained. The partition of NH4 between the renal vein and urine
therefore determines the net acid-base effect of the renal ammoniagenic
process.
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Table 1. Effect of acid-base status on arterial blood and urinary parameters in the dog (left kidney)
Acute
Acute lactate bicarbonate
Acid-base status N = 7 N 9
RBF, mi/mm
GFR,ami/mm
Urinary citrate
excretion, *
jzmole/min
Urinary anirnonium
excretion,*
pinole/min
Acidosis
Chronic
Acute HC1 Acute CO2 Acute lactic NH4CIN=7 N= 13 N6 N= 10
256 16 179 14 219 12 143 22 180 25 168 6 238 31
46 35 39 26 34 33 30
0.24 0.07 0.27 0.04 0.15 0.05 0.07 0.01 0.03 0.05 0.04 0.05
6.2 1.1 6.3 1.8 8.2 1.0 17.6 2.2 27.5 3.6 15.9 1.6
Abbreviations: RBF, renal blood flow; GFR, glomerular filtration rate.
The values were obtained from the left kidney of the dogs.
Table 2. Effect of acid-base Status on the net renal uptake of substrates by left kidney of the dog
0.01 0.01
36.4 1.8
Acid-base status Alkalosis
Normal
acid-base
Acidosis
Metabolites production Acute Chronic
(+) or utilization (—) Acute lactate bicarbonate status Acute HCI Acute CO2 Acute lactic NH4CI
jimoiesIOOmIGFR'' N7 N=9 N=16 N=7 N=l3 N=6 N10
Total NH4 +44.3 4.2 + 38.5 3.7 + 57.! 3.3 + 124.2 33.5 + 127.5 17.8 + 81.2 8.9 + 170.0 27
Glutamine —37.7 5.0 —25.7 2.4 —31.7 5.1 —57.3 7.3 —56.4 5.3 —62.1 8.1 —85.0 4.3
Glutamate +3.2 1.6 +3.7 0.9 +2.1 1.6 +7.0 2.0 +4.4 1.2 —0.4 0.2 +4.0 2.0
Alanine +37.0 8.6 + 17.8 2.5 + 18.7 2.5 + 19.0 4.6 + 10.2 5.6 47.8 4.7 +29.0 5.0
Aspartate 0 0 0 0 0 0 +5.0 3.9
Citrate —20.4 3.4 —15.9 2.7 —15.3 1.5 —21.2 7.3 —21.1 4.9 —16.2 3.3 —18 3.0
Lactate —736 225 —157 16 —159 14 —127 38 —79 1! —568 122 —83 17
Pyruvate —25.3 11.2 —7.3 4.2 —2.2 2.9 0 —4.4 2.3 + 12.9 9.9 —7.1 2.1
Gin to AA pathway' 40.2 21.5 20.8 26.0 14.6 47.4 38.0
GIn to GLDH pathwayb 0 4.2 10.9 31.3 41.8 14.7 47.0
a GIn to AA pathway: Glutamine supporting amino acid production (glutamate + alanine + aspartate): one ammonia produced per glutamine.b Gin to GLDH pathway: Glutamine deamidated to glutamate and subsequently deaminated by the glutamate dehydrogenase (GLDH) to
s-ketoglutarate: two ammonias produced per glutamine.
gastrointestinal tract [221. Because plasma glutamine is in-
creased only slightly during inorganic acidosis [10, 281 while the
glutamine turnover is unchanged by acid-base status [26], a
reduced glutamine extraction at extrarenal sites must accom-
pany the accelerated renal extraction of glutamine, suggesting
that acidosis probably has inverse effects on glutamine utiliza-
tion in the gut and kidney. Nevertheless, a small increase in
blood glutamine is observed in acutely or chronically acidotic
dogs (Table 1) except with lactic acidosis when alanine synthe-
sis rapidly consumes glutamine. This rise probably plays a
minor role in the regulation of ammoniagenesis because it is not
accompanied by an increment in the renal cortical concentra-
tion of giutamine (to be explained later in text with Table 4).
In addition to the blood glutamine concentration, one must
consider renal blood flow and glomerular filtration rate (GFR) to
evaluate the delivery of glutamine to the kidney. In most
studies, these parameters tend to fall during acute metabolic
acidosis but become normal in chronic acidosis (Table 1). The
net result is that the renal glutamine delivery to proximal
tubular cells is not changed significantly during acute acidosis in
the dog indicating that metabolic regulation must occur within
the kidney itself. In support of this conclusion, an acute
glutamine infusion does not mimic the events occurring during
chronic metabolic acidosis [29].
Table 1 also presents the arterial concentration of other
relevant metabolites during acid-base changes. During acidosis
or alkalosis, the arterial concentration of alanine remains un-
changed. Because the renal production of alanine varies widely
in these circumstances (Tables 1 and 2), the arterial concentra-
tion of this amino acid must also be regulated at an extrarenal
site, probably the liver. Lactate is also a significant substrate for
the dog kidney; therefore, changes in arterial lactate concentra-
Alkalosis
Normal
acid-base
statusN 16
Blood pH 7.46 0.03 7.52 0.02 7.33 0.01 7.10 0.02 6.97 0.03 7.09 0.03 7.22 0.03
Blood pCO2, mmHg 44.0 2.4 41.0 11 37.8 0.8 38.1 1.6 107.8 9.8 43.5 2.6 35.0 2.0
Plasma HCO3, msi 30.0 1.6 32.6 1.7 19.5 0.4 11.3 0.4 23.8 0.9 12.8 0.7 14.0 2.0
Blood glutamine, mc 0.50 0.03 0.38 0.02 0.50 0.02 0.68 0.06 0.56 0.07 0.51 0.05 0.64 0.05
Blood alanine, m 0.40 0.04 0.28 0.03 0.32 0.02 0.42 0.02 0.41 0.04 0.45 0.03 0.38 0.06
Blood lactate, mM 19.0 1.16 1.7 0.26 1.5 0.12 1.4 0.24 0.79 0.08 8.1 0.71 0.93 0.18
Blood citrate, m.i 0.12 0.01 0.11 0.01 0.11 0.01 0.08 0.02 0.12 0.01 0.11 0.01 0.06 0.01
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tion may affect its renal uptake and the regulation of the overall
renal metabolism. In the studies presented here, the spontane-
ous arterial lactate concentration was close to 1 m in normal,
acidotic, or alkalotic dogs. However, lactate concentration rose
to 8 and 19 m following infusion of lactic acid or sodium
lactate. The consequences of this for the renal metabolism of
glutamine are discussed below. Arterial citrate, another metab-
olite regularly utilized by the dog kidney, is affected only
modestly by acid-base changes. However, the urinary citrate
excretion is significantly increased during metabolic alkalosis
and decreased during acidosis (Table 1) in accord with previous
observations [301 where the pH (but not the lactate concentra-
tion) was altered.
Urinary NH4 excretion increases two- to threefold during
acute acidosis and fourfold during chronic metabolic acidosis in
the dog (Table 1). In contrast, the total ammonia production
increases only threefold during chronic metabolic acidosis
(Table 2), indicating that an intrarenal redistribution of the
ammonia produced occurs between the renal vein and the urine.
Conversely, renal ammonia production and excretion are de-
creased only modestly during alkalosis. Because the urinary
NH41 excretion reflects net bicarbonate generation (Fig. 1), it
is clear that acute and chronic changes in acid-base status
modulate this process to a major extent. Because the metabolic
effects of acid-base changes are the main topic of this review,
the mechanisms controlling the partition of the ammonia pro-
duced between the urine and the renal venous blood will not be
discussed at length; the reader is referred to a review on the
subject [51.
Effects of acid-base changes on renal utilization
of metabolites
To fully understand the metabolic processes modulating total
ammonia production by the kidney, one must consider the
simultaneous renal utilization or production of the various
metabolites presented in Table 2. The data are expressed per
100 ml of GFR to study the metabolic influences of the
acid-base status in different groups of dogs at the same rate of
substrate delivery and sodium transport, and therefore, at the
same rate of energy expenditure in the kidney.
It can be seen that total ammonia production increases during
acute metabolic and respiratory acidosis or chronic metabolic
acidosis, and decreased during acute metabolic alkalosis (Table
2). Only a fourfold span of ammonia productions is observed in
these different conditions (a much larger span is observed in the
rat). Glutamine extraction increases significantly during acute
metabolic or respiratory acidosis and even more so during
chronic metabolic acidosis. By contrast, glutamine extraction is
depressed modestly during acute bicarbonate alkalosis. Renal
glutamate release remains small and relatively unaffected by
acid-base changes. The ratio of ammonia production over
glutamine extraction is around 2.0 in normal and acidotic
animals and decreases to 1.5 in bicarbonate-infused dogs. A
superficial interpretation of this ratio would be that both
nitrogens of glutamine are released during its intrarenal metab-
olism in most circumstances. However, this ratio is possibly
fortuitously set around 2, because total ammonia production is
the net result of several ammoniagenic pathways within the
kidney cortex (see below).
Glutamine
GI:ate
Aspartate
GLDH 12 (1L2 Alanine
_________ Pyruvate I Citrate
Fig. 2. ATFformation during glutamine, lactate, and citrate metabo-
lism. For description, see text and [48]. The basis for calculating the
quantity of ATP produced in each segment of the pathway is as follows:
Each turnover of NADH is equivalent to the turnover of 3 ATPs. The
number of ATPs generated when glutamine, lactate, and citrate are
metabolized to oxaloacetate or pyruvate are indicated by the numbers
close to each arrow. The two arrows linking glutamine and pyruvate (+
oxaloacetate) represent flux through glutamate dehydrogenase (GLDH)(12 ATP) or alanine aminotransferase (9 ATP): One less NADH and
therefore 3 less ATPs are generated via the transaminase pathway to
alanine. When pyruvate is converted to glucose, 6 ATPs are consumed.
However, for gluconeogenesis from glutamine, the synthesis of
oxaloacetate by the pyruvate carboxylase enzyme is not required, and
only 5 ATPs are consumed. In both cases, 0.5 mole of glucose is formed
per mole of glutamine or lactate utilized,
Lactate utilization is a major process in normal animals and is
depressed during acute and chronic acidosis but unchanged
during acute bicarbonate alkalosis. In contrast, when lactate
accumulates in the arterial blood, its renal uptake increases
dramatically. When acidosis or alkalosis is produced by lactic
acid or sodium lactate infusion, the glutamine utilization by the
kidney exceeds the rate observed during acidosis or alkalosis in
the absence of lactate accumulation. This follows a significant
stimulation of alanine synthesis in the kidney cortex during both
lactate acidosis and alkalosis. Alanine synthesis also increases
moderately in chronic ammonium chloride acidosis, but re-
mains virtually unchanged in other acute acid-base disorders
without lactatemia. Aspartate production by the kidney remains
undetectable, except during chronic metabolic acidosis where a
small production is observed. Citrate utilization is comparable
in all acid-base conditions.
An integrated view of renal metabolic response to
acid-base changes
To understand renal ammomagenesis in an integrated fash-
ion, it is useful to follow the intrarenal reactions described in
Figure 2 and detailed below. Glutamine is taken up by the
luminal and antiluminal [31, 32] membranes of proximal tubular
cells. The antiluminal transport has been shown to be stimu-
lated by acidosis in some studies [33] but not in others [34].
Glutamine is stored temporarily in the cytosol of proximal cells
which maintain a glutamine concentration above the arterial
value (Table 3). Glutamine remains separated from phosphate-
dependent glutaminase by the mitochondrial membrane, the
Renal
vein
3
Lactate I /
CO2
—6(Lactate)
—5 (Glutamine)
1/2 Glucose
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Table 3. Relative importance of the various metabolic processes releasing ammonia in the dog kidney during acid-base disorders
Alkalosis Normal Acidosis
acid-base
Acute lactate Acute bicarbonate status Acute HCI Acute CO2 Acute lactic Chronic NH4CI
Acid-basestatus N=7 N=9 N=16 N=7 N=13 N=6 N10
Glutamine uptakea 37.7 25,7 31.7 57.3 56.4 62.1 85.0
Total NH4 productio&' 44.3 38.5 57.1 124.2 127.5 81.2 170.0
From AA pathway"' 40.2 (93%) 21.5 (56%) 20.8 (36%) 26.0 (21%) 14.6 (12%) 47.4 (58%) 38.0 (22%)
From GLDH pathway 0 8.4 (22%) 21.8 (38%) 62.6 (50%) 83.6 (66%) 29.4 (36%) 104.0 (61%)
From other sourcest 0 8.6 (22%) 14.5 (25%) 35.6 (29%) 29.3 (23%) 4.4 (5%) 28.0 (17%)
a Measured glutamine uptake.
Measured total NH4 production.
See Table 2 for definition of the pathways; data are expressed as tmoles/100 ml of GFR.
ci NH4t release due to aminoacid production (see Table 2).
NH4 release due to GLDH pathway (see Table 2).
NH4 produced from nonglutamine sources (b — Ed + ci).
Table 4. Effect of acid-base status on critical metabotites in the dog left kidney cortex
Alkalosis Normal Acidosis
acid-base
Acid-base status Acute lactate Acute bicarbonate status Acute HC1 Acute CO2 Acute lactic Chronic NH4CI
uno!esIgwetwt N=7 N9 Nl6 N7 N=13 N=6 N10
Glutamine 0.43 0.05 0.53 0.06 0.63 0.05 0.50 0.07 0.54 0.07 0.40 0.09 0.54 0.07
Glutamate 4.19 0.42 4.78 0.30 4.92 0.29 2.47 0.24 2.41 0.23 2.88 0.25 3.63 0.13
a-Ketoglutarate 0.30 0.06 0.11 0.01 0.09 0.01 0.04 0.02 0.06 0.07 0.09 0.20 0.05 0.005
Malate 0.45 0.06 0.16 0.02 0.09 0.01 0.16 0.07 0.49 0.07 0.32 0.09 0.52 0.007
Oxaloacetatea (calculated)
MDH-LDH 3.0 2.2 1.7 2.4 11.2 4.7 10.4
Asp-AT 6.7 2.2 2.2 2.4 7.1 4.1 3.6
Lactate 15.1 1.16 1.22 0.15 0.61 0.07 1.00 0.23 0.51 0.07 6.01 1.65 0.78 0.09
Pyruvate 0.41 0.05 0.05 0.01 0.06 0.01 0.06 0.02 0.05 0.01 0.19 0.03 0.06 0.005
Citrate 0.58 0.07 0.34 0.06 0.20 0.02 0.26 0.04 0.25 0.02 0.22 0.02 0.52 0.03
Alanine 1.22 0.13 0.80 0.09 0.89 0.06 0.99 0.10 0.86 0.09 1.80 0.31 1.10 0.08
Aspartate 0.66 0.05 0.77 0.09 0.87 0.05 1.00 0.09 2.08 0.18 0.94 0.17 1.66 0.17
ATP 1.35 0.14 1.36 0.09 1.59 0.06 1.22 0.10 1.46 0.10 1.43 0.05 1.61 0.07
a Oxaloacetate was calculated from the malate (MDH) and lactate (LDH) dehydrogenases systems or from the aspartate aminotransferase
system (AspAT) as previously described [101 and is expressed in jxmoles/g wet wt.
first enzyme initiating its mitoehondrial metabolism. Therefore,
glutamine must be transported across this membrane to be
deamidated to glutamate. This transport step has been consid-
ered as a possible regulatory site for glutamine metabolism and
is accelerated during chronic but not acute [351 metabolic
acidosis in the dog. However, this effect is probably not the
major control site for renal glutamine metabolism as suggested
by the changes in critical cortical metabolites (see below). In
mitochondria, glutamine is deamidated into glutamate and some
of this glutamate leaks back into the cytosol. This process,
together with the poor permeability of the cell membrane to
glutamate, keeps the cellular concentration of glutamate well
above the arterial blood concentration (Table 4). If the intracel-
lular water represents 55% of the tissue (and if no major
compartmentalization occurs in the kidney cortex) intracellular
glutamate is close to 7 m. The large concentration gradient for
glutamate between the renal tubular cells and plasma and the
incomplete impermeability of the cell membrane to glutamate
permits a small amount of this metabolite to enter the renal
vein: Normally, the kidney produces small amounts of this
amino acid. Because glutamine is the immediate precursor of
glutamate and glutamate release is increased when a glutamine
load is administered [29, 36], it can be assumed that glutamine
uptake supports this small glutamate release. This process is
therefore the first ammoniagenic process (see reaction 6).
Glutamine° —* glutamate
— + NH4 (6)
Table 2 shows that this process is influenced minimally by
acid-base changes.
The glutamate produced from glutamine and not released by
the kidney is further metabolized within the proximal tubular
cells via two types of reactions: transamination and deami-
nation (Fig. 3).
Transamination. Glutamate may be transaminated into the
kidney to form alanine or aspartate according to reactions 7 and
8.
Glutamate + pyruvate alphaketoglutarate
+ alanine°
Glutamate + oxaloaeetate alphaketoglutarate
+ aspartate
(7)
(8)
These transamination reactions can occur both in the eyto-
plasmic and mitoehondrial compartments of the dog kidney
cortex. The alanine and aspartate aminotransferase systems are
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Acid-base
regulation
Fig. 3. Metabolism of glutamine in dog proximal tubular cells: regula-
tion by pH and by substrate availability. The diagram illustrates that
glutamate (and secondarily glutamine) metabolism can be promoted
through faster deamination (because of faster a-ketoglutarate removal:
pH regulation) or faster transamination (because of elevated pyruvate
concentration: substrate regulation). In the dog kidney both pathways
usually coexist and together are responsible for the bulk of the renal
ammonia production in physiological situations. In both cases, the rate
of a-ketoglutarate metabolism is limited by the cell ATP turnover which
may therefore limit the overall rate of renal glutamine utilization.
Abbreviations are: GIn, glutamine; G1u, glutamate; aKg, a-ketoglu-
tarate; OAA, oxaloacetate.
"near-equilibrium reactions" in this organ [37], implying that a
net flux through these reactions is driven only by changes in
concentration of the substrates and/or products of these reac-
tions. Accordingly, it is probable that alanine synthesis is
promoted continuously by the net release of alanine through the
antiluminal membrane. This also indicates that renal alanine
synthesis will increase in the kidney when the glutamate or
pyruvate concentration rises or when the a-ketoglutarate or
alanine concentration falls. Table 2 illustrates that when lactate
is provided to the kidney (lactic acidosis/lactate alkalosis), more
glutamate (from glutamine deamidation) is consumed and more
alanine is produced. Because glutamate is a physiological
inhibitor of the glutaminase enzyme, more glutamine is deami-
dated to regenerate the glutamate transaminated into alanine
(Table 2, Fig. 3). The net result is an accelerated rate of glutamine
metabolism. This occurs in vitro [38] as well as in vivo.
It must be realized that the overall pathway from glutamine to
alanine is an ammoniagenic pathway (reaction 9).
Glutamine° -+ alanine° + NH4 (9)
This pathway is driven by glutamate or pyruvate accumula-
tion and will occur irrespectively of acid-base changes (Fig, 3).
The accelerated alanine synthesis explains why the total am-
monia production is greater during acute lactate alkalosis than
during acute bicarbonate alkalosis. Conversely, when glutam-
ate is transaminated rapidly (for example, when pyruvate
accumulates), the rate of deamination of glutamate by the
glutamate dehydrogenase (GLDH) enzyme will be reduced.
Therefore, the total ammonia production is significantly lower
in acute lactic acidosis than in HC1 or CO2 acidosis (Table 2).
The transamination of glutamate into alanine should also be
stimulated when the products of the reaction are removed at a
faster rate. The fall in renal alphaketoglutarate which occurs
during chronic metabolic acidosis (due to the activation of
alphaketoglutarate dehydrogenase enzyme (KGDH) by in-
creased H concentration2 [39]) therefore will drive alanine
synthesis. This is observed with chronic metabolic acidosis. It
is not observed with acute HC1 or CO2 acidosis because, in the
latter circumstances, the acute fall in tissue glutamate offsets
the effect of the fall in tissue a-ketoglutarate concentration,
preventing a significant change from occurring in the mass-
action ratio of this system.
Aspartate synthesis normally could play a similar role to
alanine synthesis, but the very low concentration of oxaloace-
tate in the kidney prevents a large aspartate synthesis rate from
j occurring during most physiological conditions. However in
chronic metabolic acidosis, renal aspartate synthesis becomes a
small but significant ammoniagenic process, (reaction 10) be-
cause oxaloacetate and malate are now appreciably higher in
concentration in the kidney cortex (Table 4).
Glutamine° — aspartate + NH4 (10)
This process is also stimulated by a glutamine infusion [36]
especially when oxaloacetate accumulates under the influence
of mercaptopicolinic acid (PEPCK block) [36, 40]. It is not
operative during sodium lactate infusion, despite a higher tissue
oxaloacetate because of competition between alanine and
aspartate aminotransferases for glutamate, and accumulation of
a-ketoglutarate.
Therefore, we propose that alanine or aspartate are synthe-
sized within the kidney by transamination of the glutamate
produced from glutamine (or of glutamine itself [381) and that
these processes release one ammonia per glutamine utilized in
this fashion (reactions 9 and 10). This assumption is supported
by the rise in renal glutamine extraction when the production of
alanine or aspartate increases (see above). Furthermore, during
lactate metabolic alkalosis, the renal glutamine extraction
equals the renal production of alanine which also equals the
total renal ammonia production by the kidney, confirming the
stoichiometry:
I Glutamine —* I alanine + 1 ammonia (11)
Clearly, this pathway is regulated by influences independent
of the acid-base status. Therefore, total ammonia production
will increase in all conditions where these transamination fluxes
are stimulated (lactate infusion, glutamine infusion,
oxaloacetate accumulation, and so forth). It should be noted that
the intrarenal metabolism of glutamine can provide both the
donor (glutamate) and the acceptor (pyruvate, oxaloacetate)
molecules for these transamination processes. This implies that
alanine may be synthetised in proximal tubules from glutamine
even if no net uptake of lactate/pyruvate is measured.
GIn
Glu -/
oKG
Glucose
Alanine
/N\\\
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regulation
2 The pH required to change KGDH activity in vitro [391 is rather
large and probably larger than the changes occurring in situ in
mitochondria during acidosis. This indicates that other factors are
probably also involved in the regulation of a KGDH activity.
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Deamination. It is now possible to calculate the amount of
glutamine entering the ammoniagenic aminoacid producing
pathway (glutamine to glutamate, alanine and aspartate; one
ammonia per glutamine). By subtracting this number from the
total glutamine extraction by the kidney, it is possible to
calculate the amount of glutamate undergoing deamination
through the GLDH pathway, that is, the amount of glutamine
undergoing complete deamidation and deamination within the
kidney cortex, (producing two ammonias per glutamine; see the
bottom of Table 2). It can be seen that the glutamine metabo-
lized through the GLDH pathway represents 30% of the total
glutamine uptake by the kidney in normal dogs. With acute
metabolic or respiratory acidosis, this flux increases three- or
fourfold and with chronic ammonium chloride metabolic acido-
sis, it increases fivefold. In contrast, it decreases somewhat
during acute bicarbonate alkalosis and it is suppressed com-
pletely with acute lactate alkalosis. It should also be noted that
the GLDH flux has a much smaller magnitude with acute lactic
acidosis than with HC1 or CO2 acidosis probably because the
aminoacid producing pathway is stimulated markedly by the
availability of pyruvate and competes for glutamate.
In summary, the intrarenal metabolism of glutamine can use
either the transamination pathways which usually are not
regulated by acid-base status or the deamination pathway
(GLDH) which is under the direct influence of the acid-base
status (Fig. 3). The majority of the ammonia production by the
kidney will reflect the sum of these two processes.
Different ammoniagenic pathways in the dog kidney
Following this analysis of glutamine metabolism within dog
proximal tubules, it is necessary to reinterpret the source of
ammonia produced in the kidney cortex. Indeed, when
glutamine undergoes transamination, one nitrogen is liberated
as ammonia while the other leaves the kidney as alanine (or
aspartate). Let us identify in the total renal ammonia produc-
tion, the two fractions arising from the aminoacid pathway
(production of glutamate, alanine, and aspartate) and the
GLDH pathway. In Table 3, in normal dogs roughly 36% of the
ammonia comes from the aminoacid pathway and an equivalent
amount from the GLDH pathway. During acute and chronic
metabolic acidosis, the relative role of the aminoacid pathway is
depressed modestly while the ammonia originating from the
GLDH pathway rises to approximately 60% of the total ammo-
nia production. In contrast, the aminoacid pathway explains
58% of the total ammonia production in lactic acidosis. During
bicarbonate alkalosis, the contribution of the amino acid path-
way increases significantly, whereas it explains the totality of
the renal ammonia production during lactate alkalosis.
Obviously, when the nitrogen extracted with glutamine is
accounted for by the deamination and transamination proces-
ses, we cannot explain all the measured renal ammonia produc-
tion. Therefore, a significant amount of ammonia (around 20%
in normal or acidotic states) has to be produced from
nonglutamine-dependent pathways (Table 3). Ammoniagenesis
by these pathways is stimulated by acidosis and suppressed by
alkalosis and the provision of lactate, indicating that these
pathways also may be regulated by acid-base changes. Al-
though the nature of these pathways has not been identified
clearly in the dog, they may be related to the uptake of other
aminoacids [5, 6], other nitrogenous products such as proteins,
or to the purine nucleotide cycle [411. Even if the ratio of
ammonia production over glutamine extraction is of 2.0 in
chronic acidosis, this appears to be a fortuitous phenomenon
due to the fact that the ammonia produced from nonglutamine-
dependent pathways is roughly of the same magnitude as the
ammonia produced by the aminoacid pathway.
Analysis of ammoniagenesis by examining changes of critical
metabolites in kidney cortex
To better understand the metabolic phenomena occurring in
the dog kidney, one should also examine the changes in renal
cortical concentration of critical metabolites during acid-base
changes. In Table 4, all values are presented as imole/g wet wt.
Therefore, all values divided by 0.55 (the percent of intracellu-
lar water) provide an estimate of their cortical concentrations in
molar terms. The renal glutamine concentration is reduced
slightly during inorganic acidosis and more markedly with lactic
acidosis or lactate alkalosis (the faster removal of glutamate
through alanine formation probably explains this observation).
Tissue glutamate concentration is reduced significantly during
acute HCI or CO2 acidosis. This can be attributed to the rapid
fall of o-ketoglutarate concentration induced by acidosis. In-
deed, the H concentration has been shown to exert a direct
effect on the a-ketoglutarate dehydrogenase activity [39].
Therefore, the near-equilibrium glutamate dehydrogenase sys-
tem (reaction 12) will be driven to the right by the lower
c-ketoglutarate concentration.
Glutamate + NAD — alphaketoglutarate
+ NH4 + NADH + H (12)
The immediate consequence will be a faster utilization of
glutamate which, in turn, increases glutamine deamidation by
de-inhibiting the mitochondrial glutaminase system. It has been
also suggested that the fall in a-ketoglutarate may directly
increase the mitochondrial permeability for glutamine, increas-
ing the delivery of this amino acid at the glutaminase activity
site [42]. There are, however, lines of evidence that this
mechanism may not be operative in vivo in the dog [431. In
chronic metabolic acidosis, the a-ketoglutarate concentration
remains low, but the glutamate level tends to rise toward the
level seen in normal dogs, possibly indicating a faster mitochon-
drial generation of glutamate. This finding is consistent with the
demonstration of an increased activity of the glutamine trans-
porter in the mitochondrial membrane of chronically acidotic
dogs [35]. Conversely, in metabolic alkalosis, the renal a-
ketoglutarate level is elevated modestly. In lactate alkalosis, the
renal a-ketoglutarate is even higher probably because a-
ketoglutarate is one of the products of the transamination
reactions which is stimulated by pyruvate availability (reactions
7 and 8) while the fall of H concentration inhibits the
decarboxylation of this metabolite. It can be concluded that the
renal concentration of a-ketoglutarate is not only modified by
acid-base changes but is also influenced by the rate of trans-
amination.
In the normal acid-base status, the malate concentration in
the kidney cortex is around 0.1 tmole/g and oxaloacetate
around 2 nmoles/g. During metabolic acidosis, a-ketoglutarate
conversion to malate is increased (through activation of a-
ketoglutarate dehydrogenase activity [391 and probably of the
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Fig. 4. Proposed pathways of glutamine and lactate metabolism in the
dog kidney proximal tubular cells. When glutamine is converted into
malate at a faster rate (acidosis), the flux through the mitochondrial
PEPCK (PEPCK,,.J is rapidly saturated. As a result, the malate concen-
tration rises until the K,,, of the malic enzyme (ME) is reached, and this
route is used to dissipate malate via oxidation to CO2. When a surplus
of substrate (glutamine, lactate) is present, the ATP turnover limits the
rate of oxaloacetate oxidation, and oxaloacetate is metabolized by the
cytoplasmic PEPCK (PEPCKC) to synthesize glucose. For abbrevi-
ations, see Figure 3.
other irreversible reactions occurring between a-ketoglutarate
and malate). When this occurs, the renal concentration of
malate rises (Fig. 4). When renal blood flow does not fall
markedly (in acute respiratory acidosis or chronic ammonium
chloride acidosis) and when the glutamine delivery to the
kidney remains optimal, the cortical concentration of malate
rises to fivefold. This increment indicates that during acidosis,
the metabolic production of malate and oxaloacetate from
glutatamine through the GLDH pathway temporarily exceeds
the renal capacity for oxaloacetate utilization. Because
oxaloacetate is used both for oxidation and gluconeogenesis
through the phosphoenolypyruvate carboxykinase (PEPCK)
pathway and because the activity of this enzyme does not
change during acid-base disorders in the dog kidney [10, 44], it
seems that an increased oxaloacetate delivery cannot propor-
tionally accelerate the flux in the PEPCK reaction, resulting in
an increment in the tissue concentration of this intermediate.
In the dog, two PEPCK enzymes are present, one in the
mitochondrial and the other in the cytoplasmic compartments
[44, 45] (Fig. 4). These two enzymes are immunologically
distinct but have similar kinetic characteristics (Km for
oxaloacetate) when tested in vitro [45] (this may not be true in
vivo). Therefore, it is possible that during acute acidosis the
mitochondrial PEPCK cannot cope with the increased produc-
tion of malate and oxaloacetate in the kidney cortex. Agreeing
with this view oxaloacetate and malate rise when an increased
St mitochondrial production of oxaloacetate is observed whatever
the source: an infusion of lactate (promoting the generation of
oxaloacetate through the pyruvate carboxylase reaction) or
chronic metabolic acidosis (accelerating the conversion of
alphaketoglutarate into malate) (Table 4).
From the above, we propose the basis of Figure 4: During
metabolic acidosis, the accelerated intramitochondrial genera-
tion of malate, elevates the malate concentration because the
intramitochondrial PEPCK flux has little reserve capacity in
normal dogs. The malate concentration rises in the kidney
cortex until a new pathway for malate/oxaloacetate utilization
becomes operative. This pathway may be the extramitochon-
drial PEPCK or another pathway. Because gluconeogenesis
from lactate is not stimulated in vitro by acidosis in the dog
kidney [46] and because inhibition of the extramitochondrial
PEPCK in vivo does not suppress the oxidation of glutamine in
acidotic dogs [40, 44, 45], the extramitochondrial PEPCK is
probably not involved in most physiological situations. We
have therefore proposed that the rise in tissue malate concen-
tration ceases when malate concentration reaches the Km for
the malic enzyme in this tissue [10, 40, 44]. This proposal
implies that the carbon skeleton of glutamine is metabolized
normally through malic enzyme into pyruvate, acetyl CoA and
thus to CO2 and not to glucose in acidotic dogs [401, This
scheme is a sharp contrast with the significant activation of the
PEPCK observed in the rat kidney during metabolic acidosis,
leading to a dramatic fall of tissue concentration of oxaloacetate
and malate and to a marked stimulation of the gluconeogenic
process as observed in vitro [8, 14, 15]. Because of these
species differences, we suggest that the dog kidney oxidizes
glutamine in contrast to the rat kidney where the gluconeogenic
pathway predominates [38, 42].
When oxaloacetate and malate are produced in large amounts
(lactate or glutamine infusions), oxaloacetate metabolism
through oxidation would exceed the maximal capacity of the
kidney to use the AlP so-formed (see below). In these circum-
stances, a gluconeogenic flux must occur in the kidney cortex.
Because this flux is suppressed by PEPCK inhibition in vivo
[361, we propose that the extramitochondrial PEPCK activity
can support a significant gluconeogenic flux following a
glutamine [36] or lactate [18] load. However, this mechanism
probably plays a minor role during physiological circumstances
in vivo (when no excess of gluconeogenic substrates is present).
We also propose that the preparation of isolated tubules [46]
duplicates in vitro a situation with excess of substrates:
Gluconeogenesis now becomes a significant metabolic fate for
glutamine.
The considerations above have obvious importance since one
of the products of glutamine transformation to CO2 or glucose is
ATP [47]. Therefore, the ATP turnover will fix the maximal rate
of the conversion of glutamine into CO2 or glucose [47, 48]. This
maximal rate will be reached when all the ATP turnover in the
nephron segment utilizing glutamine (the proximal tubule) will
be supported by glutamine metabolism. It is clear that if 1 mole
of glutamine is oxidized (in the dog) producing 27 moles of ATP,
fewer glutamine molecules can be metabolized to sustain the
LACTATE
PEPCK,,, ME PEPCK
Co2
+
ATP
Glucose
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Table 5. ATP generation from measured substrate uptake on the dog left kidney
Alkalosis
Normal
acid-base
Acidosis
Acute Acute Acute Chronic
lactate bicarbonate status Acute HC1 Acute CO2 lactic NH4CI
Acid-basestatus N7 N=9 N=16 N=7 N=13 N=6 N=lO
Total ATP turnover [66181* [3437] 3552 [33971 [3649] [57281* 3642
ATP required for Na Reabsorption 3267 2956 3054 2921 3138 3003 3087
Sources of ATP
(a) Glutamine to aspartate (A5pAT) 0 0 0 0 0 0 27
(b) Glutamine to alanine (AIaAT) 333 161 168 173 92 430 261
(c) Glutamine to pyruvate (GLDH) 0 50 131 375 502 176 564
(d) Lactate to pyruvate 2208 471 477 381 236 1704 249
(e) Citrate to pyruvate 244 191 184 254 253 192 216
W Others 728 2564 2592 2214 2566 991 2307
Total pyruvate available for oxidation 781 184 187 179 146 585 157
(a) From glutamine 0 4 11 31 42 14 49
(b) From lactate + pyruvate 761 164 161 127 83 555 90
(c) From citrate 20 16 15 21 21 16 18
Max amount of pyruvate oxidized 256 171 173 148 171 215 154
Max amount of pyruvate to glucose 525 13 14 31 0 370 4
ATP required from other substrates 0 0 0 0 375 0 0
Max ATP generated from glutamine
metabolism (% of total) 333 (5%) 271 (8%) 464 (13%) 1013 (23%) 1224 (34%) 816 (14%) 1587 (44%)
Max ATP generated from lactate
metabolism (% of total) 6048 (91%) 2931 (85%) 2908 (82%) 2286 (67%) 1481 (41%) 4929 (86%) 1599 (44%)
Max ATP generated from lactate
glutamine (% of total) (96%) (93%) (95%) (90%) (75%) (100%) (88%)
Except for 02 uptake measurements, the data were taken from Table 2, The total ATP turnover was estimated from 02 consumption (3 ATP per
0; 2 0 per 02). The ATP required for Na reabsorption was taken as the sodium reabsorption x 1/4.6 [48]. When the 02 uptake was not measured,
the total ATP turnover (ATP for sodium reabsorption + "basal" ATP) was estimated as 1.163 the Na-ATP. The ATP produced during the
transformation of glutamine, lactate, and citrate to pyruvate was calculated using the ATP equivalents described in Figure 1. The pyruvate formed
was assumed to be oxidized producing 15 ATP/pyruvate. When the ATP so produced would exceed the ATP demand, the excess pyruvate was
assumed to be metabolized through gluconeogenesis. * Since gluconeogenesis from pyruvate is an ATP (and 02) consuming process (6
ATP/pyruvate), pyruvate oxidation was assumed to support this synthesis, and the calculation of total ATP turnover took this new ATPase into
account. Direct measurement of renal 02 uptake during hypoxemie lactic acidosis [54] has demonstrated that these assumptions are probably
correct.
totality of the ATP turnover than if glutamine were metabolized
to glucose producing only 7 ATPs per glutamine (Fig. 2). These
considerations may explain why the stimulation of renal ammo-
niagenesis by acidosis is roughly four times greater in the rat
kidney cortex than in the dog kidney cortex.
Renal ammoniagenesis and ATP turnover
We have pointed out recently that the intrarenal metabolism
of glutamine, which occurs primarily in proximal tubular cells,
generates ATP (47—48]. Therefore, we compared the rate of
ATP production expected from glutamine metabolism to the
overall ATP turnover in proximal segments of the nephron.
Indeed, if the ATP produced from glutamine metabolism ap-
proaches the turnover existing in situ, the latter limits the
maximal velocity of the ammoniagenie process: The cells
cannot synthesize more ATP than there is ADP to phosphoryl-
ate. Because the various ammoniagenic pathways utilizing
glutamine (glucose formation, aminoacids formation, or com-
plete oxidation) will provide different amounts of ATP (Fig. 2),
this theoretical maximal ammoniagenesis will differ according
to the pathway(s) used for glutamine metabolism in situ.
Previously, we suggested that in the dog ATP turnover could
limit the proximal glutamine metabolism during chronic meta-
bolic acidosis [47—48]. Next, we will examine the sources of
ATP in the kidney during the various acid-base disorders
presented in this review and calculate how much ATP can be
provided by the renal metabolism of glutamine, lactate, and
citrate under these circumstances.
The rate of renal oxygen consumption is the best basis to
estimate total ATP production by the kidney. Most investiga-
tors consider that virtually all ATP synthesis in the renal cortex
is of mitochondrial origin and that glycolytic ATP production in
the medulla is relatively small. The total ATP production per
100 ml of GFR was estimated in normal dogs and dogs with
chronic metabolic aeidosis from the measurement of renal
oxygen uptake (3 ATP per 0; 2 Os per 02) (Table 5, line 1). It
can be seen that around 3500 jimoles of ATP are used per 100
ml of GFR. Because most of the ATP in the kidney is utilized to
support sodium reabsorption, and because ATP turnover varies
linearly with this function, it has been calculated that around 4.6
moles of sodium are reabsorbed per mole of ATP utilized in the
dog kidney [49]. Using this number, one can calculate the total
ATP required for sodium reabsorption, that is, around 3000
ATPs per 100 ml of GFR. It should be noted that the ratio of 4.6
differs from the theoretical stoiehiometry of the Na-K-ATPase
(3 sodium per ATP hydrolyzed) and presumably reflects the
passive component of proximal sodium reabsorption (for re-
view, see [49]). The difference of around 500 ,ctmoles/100 ml of
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GFR between ATP produced and ATP required for sodium
reabsorption represents the ATP turnover unrelated to unidi-
rectional sodium transport within the kidney ("basal" ATP
expenditure, around 14% of the total turnover). Using the
measured ratio between the total ATP turnover and the ATP
required for sodium reabsorption observed in normal or chron-
ically acidotic dogs, it is possible to estimate the total ATP
turnover for experiments where oxygen consumption was not
measured. Some incertitude is present in this calculation, but
this estimation is not likely to be very different from reality.
To examine the generation of ATP in the kidney during
acid-base disorders, the major substrates taken up by the
kidney (that is, glutamine, lactate, and citrate) must be consid-
ered. The theoretical amounts of ATP produced when
glutamine is transaminated to aspartate or alanine, oxidized to
oxaloacetate, and further metabolized to glucose or CO2 are
presented in Figure 2. Using these numbers and the calculated
amounts of glutamine metabolized through amino acid synthe-
sis and GLDH pathway, it is possible to estimate the amount of
ATP produced when glutamine is metabolized and ultimately
converted to oxaloacetate, a "pyruvate equivalent" (Fig. 2 and
Table 5). The ATP produced during glutamine, lactate, and
citrate transformation into pyruvate or "pyruvate equivalents"
is presented in Table 5, lines c, d, and e. Note that a large
amount of ATP is produced through transamination of
glutamine only when lactate uptake by the kidney is stimulated
significantly. When the sum of the ATP produced by these
various processes is subtracted from the total ATP turnover,
the amount of ATP required from other reactions is obtained.
However, the pyruvate equivalents formed may now enter the
oxidative (or gluconeogenic) pathways further generating (or
consuming) ATP. Since 15 ATPs are produced when one
pyruvate is oxidized to C02, it is possible to examine if enough
pyruvate is provided to support this residual ATP need. In other
words, the maximal amount of pyruvate oxidized can be
estimated by dividing the residual ATP need (Table 5, line 1) by
15.
It is possible to compare the total amount of pyruvate
available for oxidation to the maximal amount of pyruvate
oxidized: It is obvious that these two numbers matched rather
closely, except when lactate uptake by the kidney was en-
hanced significantly by the lactate infusion protocols. In this
condition, a significant amount of pyruvate cannot be oxidized
in the kidney while keeping this organ in ATP balance. In this
situation, it is therefore necessary to assume the presence of a
significant gluconeogenic process.
Note that when glutamine, lactate, and citrate metabolism are
examined together, the total ATP needs of the kidney can be
supplied by these substrates. Furthermore, the sum of ATP
generated from glutamine plus lactate may cover most of the
ATP turnover, a reciprocal relationship being observed be-
tween the ATP formed from both substrates. This is illustrated
in Figure 5, where the sources of the bulk of the renal ATP
change reciprocally from lactate to glutamine, the extreme
situations being found with the infusion of each substrate, This
could indicate that almost no substrates other than the ones
described here are quantitatively necessary to maintain the
kidney in ATP balance. However, if other substrates such as
fatty acids or ketone bodies are metabolized to a significant
extent, less pyruvate derived from glutamine, lactate, or citrate
I I I
20 40 60 80 100
% ATP from glutamine
Fig. 5. Relationship between the maximal ATP produced from lactate
and glutamine in the dog kidney. The maximal amount of ATP
produced from glutamine and lactate oxidation by the kidney was
calculated, as was the fraction of the total ATP turnover supported by
these processes. This relationship is shown during various acid-base
disorders (points) and the total ATP turnover (line).
could enter the Krebs cycle and more would have to go
elsewhere, presumably to glucose. The absence of significant
fat oxidation in the dog kidney in vivo under most physiological
circumstances is suggested by the respiratory quotient greater
than 1.0 in this organ [50] and by the measurement of the renal
CO2 release which appears to be incompatible with a significant
oxidation of long-chain fatty acids in this organ, at least during
acidosis.
The maximal amount of ATP generated from glutamine can
be calculated by adding together the ATP produced when
glutamine is transformed to pyruvate equivalents through the
amino transferases or GLDH pathways and the ATP produced
when these pyruvate equivalents are oxidized in the kidney
(Table 5). Only 13% of the total ATP turnover is supported by
glutamine in normal dogs and 5 to 8% in alkalotic dogs.
However, this value rises to around 30% with acute acidosis of
inorganic origin and to 44% with chronic acidosis. It should be
noted that the bulk of glutamine is metabolized in the proximal
tubules; if 44% of the total renal ATP is utilized at this site, the
ATP turnover may indeed limit the maximal velocity of renal
glutamine metabolism [47, 48]. Since the bulk of ATP utilization
probably occurs in proximal kidney tubules, the fact that
glutamine is metabolized at this site allows significant changes
of the rate of glutamine oxidation to occur with changes in H
concentration.
If a pathway producing less ATP is used to metabolize
glutamine, (that is, transamination, gluconeogenesis), the max-
imal amount of ATP generated per molecule of glutamine will
be smaller and the net renal uptake could theoretically increase;
this seems to occur in acute lactic acidosis. Note that a
reciprocal relationship is observed between the maximal
amount of ATP generated from lactate and glutamine metabo-
lism (Table 5, Fig. 5). It can be calculated that in chronically
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acidotic dogs close to hail' of the ATP may come from glutamine
and a similar amount may be derived from lactate. In contrast,
in alkalotic dogs only 8% of the ATP needs may come from
glutamine while 85% can be generated from lactate metabolism.
In all these circumstances, the combined metabolism of lactate
and glutamine is sufficient to explain between 75 and 100% of
the total renal ATP turnover (Fig. 5 and Table 5, last line). This
calculation suggests that gluconeogenesis does not need to be
a major process for the dog kidney in vivo when the blood
lactate concentration is not elevated markedly.
From these considerations, it is possible therefore to suggest
that the rate of ATP turnover in the proximal tubules may set a
maximal limit to the rate of ammonia production at this site [47,
48]. In chronically acidotic animals, this limit is almost reached
spontaneously [48], which provides an explanation for the
dramatic antiammoniagenic effect of ketone bodies [37, 51] or
fatty acids [52] when administered to acidotic dogs. Indeed, by
providing another source of ATP, this maneuver will drastically
limit the maximal amount of "pyruvate equivalents" oxidized
in proximal tubules and therefore will limit glutamine oxidation
in the kidney of acidotic dogs. It should be recalled that fatty
acids or ketone bodies have a much smaller effect on renal
ammoniagenesis in species able to transform most of the
extracted glutamine into glucose, that is, the acidotic rat [53].
It should be realized that with the same limiting ATP turn-
over, the amount of glutamine metabolized and ammonia-
genesis in the kidney may vary according to the metabolic
pathways used. This may be specially relevant for nonphysio-
logical (experimental) situations. For example, when the am-
moniagenic pathway culminates in the quantitative release of
a-ketoglutarate in the urine and renal vein (maleate intoxicated
dogs) only 3 ATPs are produced per glutamine metabolized and
therefore the maximal ammoniagenic capacity of the kidney is
nine times greater than the one expected if 100% of the
glutamine metabolized undergoes complete oxidation [50].
Alternatively, if a greater fraction of glutamine enters the
pathways of transamination (9 ATP) or gluconeogenesis (7
ATP) (lactate or glutamine infusion) the maximal ammonia-
genesis is three times greater than the one observed when renal
oxidation is used to dissipate the skeleton carbon of glutamine.
Different mixtures of these pathways will produce different
rates of ammonia production. In vivo, however, the situation is
usually more simple, as shown above.
Summary
In summary, we propose: (1) that renal ammoniagenesis is
regulated both by factors dependent and independent of the
acid-base status, the net effect of the ammoniagenic process on
the proton balance being directly related to the rate of urinary
ammonium excretion; (2) that the renal metabolism of
glutamine should not be examined independently of the metab-
olism of other substrate physiologically taken up by the kidney;
(3) that different pathways for glutamine metabolism will
change during acid-base disorders of organic or nonorganic
origin; (4) that, among the main glutamine utilizing pathways,
only the GLDH pathway is influenced directly by the acid-base
status; the ammoniagenic transamination pathways is regulated
by substrate availability in the kidney; (5) that the lowest
ammoniagenic flux in the kidney coincides with the rate of
alanine production since alanine appears to derive directly from
glutamine. When this pathway is stimulated without concomit-
tant acidosis, most of the ammonia produced is not excreted in
urine but released in the renal venous blood: thus, no significant
effect on the acid-base balance is produced; (6) that glutamine is
metabolized by proximal kidney tubules of acidotic dogs prob-
ably through net oxidation; (7) that the quantitative analysis of
the metabolic consequence of this process indicates that the
rate of ATP turnover at this site may effectively place an upper
limit to the rate of glutamine oxidation, and ammonia produc-
tion by the kidney, and that this limit is nearly reached in
chronically acidotic animals.
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